Anti-tumor necrosis factor alpha treatment with adalimumab improves significantly endothelial function and decreases inflammatory process in patients with chronic psoriasis

被引:47
作者
Avgerinou, Georgia [2 ]
Tousoulis, Dimitris [1 ]
Siasos, Gerasimos [1 ]
Oikonomou, Evaggelos [1 ]
Maniatis, Konstantinos [1 ]
Papageorgiou, Nikolaos [1 ]
Paraskevopoulos, Theodoros [1 ]
Miliou, Antigoni [1 ]
Koumaki, Dimitra [2 ]
Latsios, George [1 ]
Therianiou, Anastasia [1 ,2 ]
Trikas, Athanasios [1 ]
Kampoli, Anna Maria [1 ]
Stefanadis, Christodoulos [1 ]
机构
[1] Univ Athens, Sch Med, Hippokrat Hosp, Cardiol Unit 1, Athens 11528, Greece
[2] Univ Athens, Dept Dermatol 1, A Sygros Hosp, Athens 11528, Greece
关键词
Inflammation; Adalimumab; Psoriasis; Endothelium; REPORTED OUTCOMES; TRIAL; RISK;
D O I
10.1016/j.ijcard.2011.06.112
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:382 / 383
页数:2
相关论文
共 50 条
  • [1] Anti-tumor necrosis factor-α treatment improves endothelial function in patients with rheumatoid arthritis
    Hürlimann, D
    Forster, A
    Noll, G
    Enseleit, F
    Chenevard, R
    Distler, O
    Béchir, M
    Spieker, LE
    Neidhart, M
    Michel, BA
    Gay, RE
    Lüscher, TF
    Gay, S
    Ruschitzka, F
    CIRCULATION, 2002, 106 (17) : 2184 - 2187
  • [2] Anti-tumor necrosis factor-alpha therapy improves endothelial function and arterial stiffness in patients with moderate to severe psoriasis: A 6-month prospective study
    Pina, Trinitario
    Corrales, Alfonso
    Lopez-Mejias, Raquel
    Armesto, Susana
    Gonzalez-Lopez, Marcos A.
    Gomez-Acebo, Ines
    Ubilla, Begona
    Remuzgo-Martinez, Sara
    Gonzalez-Vela, M. Carmen
    Blanco, Ricardo
    Hernandez, Jose L.
    Llorca, Javier
    Gonzalez-Gay, Miguel A.
    JOURNAL OF DERMATOLOGY, 2016, 43 (11) : 1267 - 1272
  • [3] Adalimumab (Humira™): A promising monoclonal anti-tumor necrosis factor alpha in ophthalmology
    Neri P.
    Zucchi M.
    Allegri P.
    Lettieri M.
    Mariotti C.
    Giovannini A.
    International Ophthalmology, 2011, 31 (2) : 165 - 173
  • [4] Erythema multiforme during anti-tumor necrosis factor treatment for plaque psoriasis
    Ahdout, Jennifer
    Haley, Jennifer C.
    Chiu, Melvin W.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (05) : 874 - 879
  • [5] Anti-tumor necrosis factor alpha therapy (adalimumab) in Rasmussen's encephalitis: An open pilot study
    Lagarde, Stanislas
    Villeneuve, Nathalie
    Trebuchon, Agnes
    Kaphan, Elsa
    Lepine, Anne
    McGonigal, Aileen
    Roubertie, Agathe
    Barthez, Marie-Anne J.
    Trommsdorff, Valerie
    Lefranc, Jeremie
    Wehbi, Samer
    des Portes, Vincent
    Laguitton, Virginie
    Quartier, Pierre
    Scavarda, Didier
    Giusiano, Bernard
    Milh, Mathieu
    Bulteau, Christine
    Bartolomei, Fabrice
    EPILEPSIA, 2016, 57 (06) : 956 - 966
  • [6] Tumor necrosis factor-alpha antagonism with etanercept improves endothelial progenitor cell counts in patients with psoriasis Etanercept, vascular function and endothelial progenitor cells in psoriasis
    Hayek, Salim S.
    Neuman, Robert
    Kavtaradze, Nino
    Sher, Salman
    Jones, Dean
    Li, Qunna
    Zhao, Liping
    Chen, Suephy C.
    Waller, Edmund
    Quyyumi, Arshed
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 182 : 387 - 389
  • [7] Anti-Tumor Necrosis Factor-alpha Therapy in the Management of Psoriasis and B-Chronic Lymphocytic Leukemia
    Balato, Anna
    Lembo, Serena
    Cirillo, Teresa
    Megna, Matteo
    Raimondo, Annunziata
    Di Costanzo, Luisa
    CASE REPORTS IN DERMATOLOGY, 2011, 3 (01): : 60 - 63
  • [8] Psoriasis Induced by Anti-Tumor Necrosis Factor Alpha Agents: A Comprehensive Review of the Literature
    Ciccarelli, Fedra
    De Martinis, Massimo
    Sirufo, Maria Maddalena
    Ginaldi, Lia
    ACTA DERMATOVENEROLOGICA CROATICA, 2016, 24 (03) : 169 - 174
  • [9] Combination therapy of cyclosporine and anti-tumor necrosis factor in psoriasis: a case series of 10 patients
    Barak, Eran Cohen
    Kerner, Miryam
    Rozenman, Dganit
    Ziv, Michael
    DERMATOLOGIC THERAPY, 2015, 28 (03) : 126 - 130
  • [10] Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor α antibody
    Gonzalez-Juanatey, C
    Testa, A
    Garcia-Castelo, A
    Garcia-Porrua, C
    Llorca, J
    Gonzalez-Gay, MA
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2004, 51 (03): : 447 - 450